BIOTALYS NV
Ownership & governance
Executives 5Directors 6Avg age 65Avg tenure 4.2y
CB
Carlo Boutton
Chief Executive Officer
Since 2026-03-16
+10
Executives5
CB
Carlo Boutton
Chief Executive Officer
Since 2026-03-16
LF
Luc van fraeyenhoven
Director of Finance/CFO
Since 2025-05-25
TM
Toon Musschoot
Investor Relations Contact
—
SS
Sophie Snijders
Human Resources Officer
Since 2023-11-28
EH
Eva van Hende
General Counsel
Since 2023-11-28
Board of directors6
SM
Simon Moroney
Chairman
Age 67Since 2021-03-31
PB
Pieter Robrecht Bevernage
Director/Board Member
Age 58Since 2018-12-31
JC
Johan Cardoen
Director/Board Member
Age 67Since 2012-12-31
MC
Michiel van Lookeren Campagne
Director/Board Member
Age 66Since 2022-05-31
PH
Patrik Haesen
Director/Board Member
—Since 2023-08-20
TB
Toni Bucci
Director/Board Member
—Since 2025-04-21
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| ACKERMANS & VAN HAAREN NV | 12.7 % | 5,769,470 |
| Agri Investment Fund | 10.39 % | 4,720,650 |
| Gimv (Private Equity) | 9.479 % | 4,307,621 |
| Sofinnova Partners SAS | 9.312 % | 4,231,700 |
| Madeli Participaties BV | 4.286 % | 1,947,792 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 5.03Range 3.4–6Analysts 3
3.4Mean 5.036
- Buy 2
- Hold 1
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.